Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 1
2013 2
2014 1
2015 1
2016 1
2017 3
2018 7
2019 6
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial.
Kahl S, Gancheva S, Straßburger K, Herder C, Machann J, Katsuyama H, Kabisch S, Henkel E, Kopf S, Lagerpusch M, Kantartzis K, Kupriyanova Y, Markgraf D, van Gemert T, Knebel B, Wolkersdorfer MF, Kuss O, Hwang JH, Bornstein SR, Kasperk C, Stefan N, Pfeiffer A, Birkenfeld AL, Roden M. Kahl S, et al. Among authors: kabisch s. Diabetes Care. 2020 Feb;43(2):298-305. doi: 10.2337/dc19-0641. Epub 2019 Sep 20. Diabetes Care. 2020. PMID: 31540903 Clinical Trial.
Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study.
Zaharia OP, Strassburger K, Strom A, Bönhof GJ, Karusheva Y, Antoniou S, Bódis K, Markgraf DF, Burkart V, Müssig K, Hwang JH, Asplund O, Groop L, Ahlqvist E, Seissler J, Nawroth P, Kopf S, Schmid SM, Stumvoll M, Pfeiffer AFH, Kabisch S, Tselmin S, Häring HU, Ziegler D, Kuss O, Szendroedi J, Roden M; German Diabetes Study Group. Zaharia OP, et al. Among authors: kabisch s. Lancet Diabetes Endocrinol. 2019 Sep;7(9):684-694. doi: 10.1016/S2213-8587(19)30187-1. Epub 2019 Jul 22. Lancet Diabetes Endocrinol. 2019. PMID: 31345776
Liver Fat Scores Moderately Reflect Interventional Changes in Liver Fat Content by a Low-Fat Diet but Not by a Low-Carb Diet.
Kabisch S, Bäther S, Dambeck U, Kemper M, Gerbracht C, Honsek C, Sachno A, Pfeiffer AFH. Kabisch S, et al. Nutrients. 2018 Jan 31;10(2):157. doi: 10.3390/nu10020157. Nutrients. 2018. PMID: 29385034 Free PMC article. Clinical Trial.
Acute Endothelial Benefits of Fat Restriction over Carbohydrate Restriction in Type 2 Diabetes Mellitus: Beyond Carbs and Fats.
Barbosa-Yañez RL, Dambeck U, Li L, Machann J, Kabisch S, Pfeiffer AFH. Barbosa-Yañez RL, et al. Among authors: kabisch s. Nutrients. 2018 Dec 1;10(12):1859. doi: 10.3390/nu10121859. Nutrients. 2018. PMID: 30513768 Free PMC article. Clinical Trial.
Fibre supplementation for the prevention of type 2 diabetes and improvement of glucose metabolism: the randomised controlled Optimal Fibre Trial (OptiFiT).
Honsek C, Kabisch S, Kemper M, Gerbracht C, Arafat AM, Birkenfeld AL, Dambeck U, Osterhoff MA, Weickert MO, Pfeiffer AFH. Honsek C, et al. Among authors: kabisch s. Diabetologia. 2018 Jun;61(6):1295-1305. doi: 10.1007/s00125-018-4582-6. Epub 2018 Feb 28. Diabetologia. 2018. PMID: 29492637 Clinical Trial.
Predictive effect of GIPR SNP rs10423928 on glucose metabolism liver fat and adiposity in prediabetic and diabetic subjects.
Barbosa-Yañez RL, Markova M, Dambeck U, Honsek C, Machann J, Schüler R, Kabisch S, Pfeiffer AFH. Barbosa-Yañez RL, et al. Among authors: kabisch s. Peptides. 2020 Mar;125:170237. doi: 10.1016/j.peptides.2019.170237. Epub 2019 Dec 23. Peptides. 2020. PMID: 31874232 Review.
Nutrigenetic effects in metabolic syndrome - A cornerstone for individualized therapy.
Kabisch S. Kabisch S. J Diabetes Complications. 2019 Mar;33(3):193-194. doi: 10.1016/j.jdiacomp.2018.11.008. Epub 2018 Nov 28. J Diabetes Complications. 2019. PMID: 30651177 No abstract available.
VEGF and GLUT1 are highly heritable, inversely correlated and affected by dietary fat intake: Consequences for cognitive function in humans.
Schüler R, Seebeck N, Osterhoff MA, Witte V, Flöel A, Busjahn A, Jais A, Brüning JC, Frahnow T, Kabisch S, Pivovarova O, Hornemann S, Kruse M, Pfeiffer AFH. Schüler R, et al. Among authors: kabisch s. Mol Metab. 2018 May;11:129-136. doi: 10.1016/j.molmet.2018.02.004. Epub 2018 Feb 12. Mol Metab. 2018. PMID: 29506909 Free PMC article. Clinical Trial.
Obesity Does Not Modulate the Glycometabolic Benefit of Insoluble Cereal Fibre in Subjects with Prediabetes-A Stratified Post Hoc Analysis of the Optimal Fibre Trial (OptiFiT).
Kabisch S, Meyer NMT, Honsek C, Gerbracht C, Dambeck U, Kemper M, Osterhoff MA, Birkenfeld AL, Arafat AM, Weickert MO, Pfeiffer AFH. Kabisch S, et al. Nutrients. 2019 Nov 11;11(11):2726. doi: 10.3390/nu11112726. Nutrients. 2019. PMID: 31717901 Free PMC article. Clinical Trial.
Fasting Glucose State Determines Metabolic Response to Supplementation with Insoluble Cereal Fibre: A Secondary Analysis of the Optimal Fibre Trial (OptiFiT).
Kabisch S, Meyer NMT, Honsek C, Gerbracht C, Dambeck U, Kemper M, Osterhoff MA, Birkenfeld AL, Arafat AM, Hjorth MF, Weickert MO, Pfeiffer AFH. Kabisch S, et al. Nutrients. 2019 Oct 6;11(10):2385. doi: 10.3390/nu11102385. Nutrients. 2019. PMID: 31590438 Free PMC article.
22 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback